EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of the Characteristics and Prognostic Impact of t(3;5)(q25;q35)/NPM1::MLF1 Fusion Genes and NPM1 Mutations in Acute Myeloid Leukemia Patients

Jielei Qiu, Yili Huang, Yanjie He, Xiaonan Lin, Xiaoling Xie, Yuhua Li

Clinical Lymphoma Myeloma and Leukemia · 2026-11 · 26 (11) · 751-759

DOI: 10.1016/j.clml.2026.08.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2026-11. Verfasst von Jielei Qiu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China; Guangdong Engineering Research Center of Precision Immune…. Hauptthemen laut MEDLINE: Nucleophosmin, Leukemia, Myeloid, Acute, Mutation, Translocation, Genetic. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project, Basic and Applied Basic Research Foundation of Guangdong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: NPM1::MLF1/t(3;5)(q25;q35) is a rare non-random genetic abnormality appearing in less than 0.5% of acute myeloid leukemia (AML) cases. Previous research has suggested that the NPM1 fusion gene has biological traits with NPM1 mutations. Meanwhile, there is still controversy over the classification of risk levels of AML with NPM1::MLF1. AIMS: To investigate the clinical features and prognostic significance of this subtype and NPM1 mutations in patients with AML. METHODS: To construct the cohort, we sourced patients from the Database and literatures from 1985 to 2025. Baseline clinical and laboratory characteristics of this group were compared with those of a reference cohort consisting of 643 AML patients and a subset of 46 AML patients with NPM1 mutations, all of whom were treated at our institution. RESULTS: AML patients with NPM1::MLF1 and NPM1 mutations showed statistically significant differences in age of onset, FAB typing, treatment and prognosis. Pediatric patients with NPM1::MLF1 were mainly concentrated in FAB M2 type, demonstrating high remission and low recurrence rates. While adult patients who are concentrated in the FAB M6 type, were mostly young men with high remission and high recurrence rates differ from pediatric patients . Age (> 50)may constitute a risk factor, whereas hematopoietic stem cell transplantation (HSCT) could serve as a protective factor against the high relapse rate. CONCLUSIONS: We identified NPM1::MLF1 as a detrimental risk factor and NPM1 mutations as a favorable risk factor in adults, as their survival rates differ significantly. Reducing the recurrence rate and developing treatment strategies for patients ineligible for HSCT continues to be a challenge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NucleophosminLeukemia, Myeloid, AcuteMutationTranslocation, GeneticOncogene Proteins, FusionHumansPrognosisMaleFemaleAdultMiddle AgedAdolescentChildYoung AdultAgedChild, PreschoolNuclear ProteinsDNA-Binding ProteinsCell Cycle Proteins

Stichwörter der Autor:innen

AMLNPM1 rearrangementNucleophosmin 1 (NPM1)PrognosisSurvival analysis

Substanzen

NucleophosminNPM1 protein, humanMLF1 protein, humanOncogene Proteins, FusionNuclear ProteinsDNA-Binding ProteinsCell Cycle Proteins

Autor:innen und Institutionen

  • Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China; Guangdong Engineering Research Center of Precision Immune Cell Therapy Technology, Guangzhou, China.
  • Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.
  • Guangdong Engineering Research Center of Precision Immune Cell Therapy Technology, Guangzhou, China.
  • Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China; Guangdong Engineering Research Center of Precision Immune Cell Therapy Technology, Guangzhou, China. Electronic address: liyuhu…

Förderung

  • National Natural Science Foundation of China
  • National Science and Technology Major Project
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Qiu, J., Huang, Y., He, Y., Lin, X., Xie, X., & Li, Y. (2026). Identification of the Characteristics and Prognostic Impact of t(3;5)(q25;q35)/NPM1::MLF1 Fusion Genes and NPM1 Mutations in Acute Myeloid Leukemia Patients. Clinical Lymphoma Myeloma and Leukemia, 26(11), 751-759. https://doi.org/10.1016/j.clml.2026.08.007

Vancouver

Qiu J, Huang Y, He Y, Lin X, Xie X, Li Y. Identification of the Characteristics and Prognostic Impact of t(3;5)(q25;q35)/NPM1::MLF1 Fusion Genes and NPM1 Mutations in Acute Myeloid Leukemia Patients. Clinical Lymphoma Myeloma and Leukemia. 2026;26(11):751-759. doi:10.1016/j.clml.2026.08.007

BibTeX
@article{Qiu2026,
  author = {Qiu, Jielei and Huang, Yili and He, Yanjie and Lin, Xiaonan and Xie, Xiaoling and Li, Yuhua},
  title = {Identification of the Characteristics and Prognostic Impact of t(3;5)(q25;q35)/NPM1::MLF1 Fusion Genes and NPM1 Mutations in Acute Myeloid Leukemia Patients},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2026},
  volume = {26},
  number = {11},
  pages = {751--759},
  doi = {10.1016/j.clml.2026.08.007}
}
Kostenlos starten →